Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in aortic stenosis - Is this the light at the end of the tunnel for patients with aortic stenosis?

The exploratory analysis of FOURIER trial has offered a ray of hope for patients with nonrheumatic aortic stenosis (AS). At present, the only definitive treatment of severe AS is aortic valve replacement (AVR). Despite transaortic valvular replacement revolutionizing the treatment of AS, it still re...

Descripción completa

Detalles Bibliográficos
Autores principales: Agstam, Sourabh, Agarwal, Tushar, Gupta, Anunay, Bansal, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Opinion Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065365/
https://www.ncbi.nlm.nih.gov/pubmed/33865531
http://dx.doi.org/10.1016/j.ihj.2021.01.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065365/
https://www.ncbi.nlm.nih.gov/pubmed/33865531
http://dx.doi.org/10.1016/j.ihj.2021.01.017

Ejemplares similares